Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

161.98 +5.66 (+3.62%)

Delayed Quote Updated: 3:04 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

26 27 Next >

5 Top Stocks for July ↗

July 01, 2023

This basket of stocks has it all, including growth, dividend income, and value.

Via The Motley Fool

Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock

June 30, 2023

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Why Shares of Axsome Therapeutics Fell Wednesday ↗

June 28, 2023

The biopharmaceutical company announced a $225 million stock sale.

Via The Motley Fool

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

2 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

June 28, 2023

These companies are coming into their own.

Via The Motley Fool

Why Is Xponential Fitness (XPOF) Stock Up 19% Today? ↗

June 28, 2023

Xponential Fitness (XPOF) stock is climbing higher on Wednesday as the company strikes back against a short report from Fuzzy Panda Research.

Via InvestorPlace

Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today? ↗

June 28, 2023

Axsome Therapeutics (AXSM) stock is heading lower on Wednesday as investors react to the company pricing a public share offering.

Via InvestorPlace

Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock

June 28, 2023

From Axsome Therapeutics, Inc.

Via GlobeNewswire

As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock ↗

June 28, 2023

Markets could have a tough time building on gains from Tuesday.

Via The Motley Fool

Where Will Axsome Therapeutics Be in 3 Years? ↗

June 20, 2023

The stock soared more than 100% last year.

Via The Motley Fool

This Stock Crushed the Market Last Year. Here's Why It Could Do That Again. ↗

June 16, 2023

This small biotech could become much bigger in just a few years.

Via The Motley Fool

Is Axsome Therapeutics Stock a Screaming Buy? ↗

June 15, 2023

The biotech could be staring down an enormous commercial opportunity.

Via The Motley Fool

Axsome Therapeutics Stock Is Moving Lower: What's Going On? ↗

June 28, 2023

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading lower Wednesday after the company proposed a public offering of common stock.

Via Benzinga

The Best Stocks to Invest $20,000 in Right Now ↗

June 28, 2023

You can invest in these companies with $20,000 -- or even a lot less.

Via The Motley Fool

Axsome Therapeutics Announces Proposed Public Offering of Common Stock

June 27, 2023

From Axsome Therapeutics, Inc.

Via GlobeNewswire

2 Low-Priced Stocks That Could Make You Richer ↗

June 26, 2023

These two low-priced healthcare stocks could skyrocket within the next 12 months.

Via The Motley Fool

3 Monster Stocks in the Making to Buy Right Now ↗

June 25, 2023

They're not monsters now -- but just give them some time.

Via The Motley Fool

Why Axsome Therapeutics Stock Is Rising Today ↗

June 14, 2023

Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares are trading higher Wednesday following a recent corporate presentation.

Via Benzinga

Analyst Expectations for Axsome Therapeutics's Future ↗

June 12, 2023

Via Benzinga

3 Biotech Stocks to Buy as Companies Ink Major Deals ↗

June 22, 2023

Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy.

Via InvestorPlace

Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now? ↗

June 17, 2023

Soaring sales of a new depression treatment could be just the tip of the iceberg for Axsome Therapeutics.

Via The Motley Fool

Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review ↗

June 16, 2023

Stocks kept powering higher despite, but the Nasdaq is looking extended.

Via Investor's Business Daily

Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts ↗

June 14, 2023

The company's biggest products treats depression and could be used in other conditions.

Via Investor's Business Daily

3 No-Brainer Stocks to Buy in June ↗

June 10, 2023

These biopharma stocks could be big winners.

Via The Motley Fool

The Top Healthcare Stocks to Buy With $100 ↗

June 09, 2023

You don't need a fortune to start investing.

Via The Motley Fool

Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023

June 01, 2023

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apnea

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

May 30, 2023

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Prediction: These 2 Stocks Could Double In the Next Year ↗

May 28, 2023

It would be a continuation of solid recent performances.

Via The Motley Fool

2 Biotech Stocks That Could Help Set You Up for Life ↗

May 26, 2023

These two promising companies have the potential to beat the market over time.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 22, 2023

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

All News about Axsome Therapeutics, Inc. - Common Stock

Starting at /week.